These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 14986243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM.
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P, Koirala S, Parija SC, Hansdak SG, Das ML.
    Southeast Asian J Trop Med Public Health; 1998 Mar 01; 29(1):154-8. PubMed ID: 9740292
    [Abstract] [Full Text] [Related]

  • 11. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A, Lelmett JM, Diesfeld HJ.
    J Trop Med Hyg; 1986 Apr 01; 89(2):91-104. PubMed ID: 3021967
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Post kala-azar dermal leishmaniasis: the Kenyan experience.
    Muigai R, Gachihi GS, Oster CN, Were JB, Nyakundi PM, Chunge CN, Kirigi G, Rashid JR.
    East Afr Med J; 1991 Oct 01; 68(10):801-6. PubMed ID: 1667521
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP.
    Trans R Soc Trop Med Hyg; 1984 Oct 01; 78(3):391-8. PubMed ID: 6087515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA, Chowdhury MA, Azhar MA, Rafiqueuddin AK, Azad KA.
    Med J Malaysia; 1996 Mar 01; 51(1):29-32. PubMed ID: 10967976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.